Stasia Obremskey

Stasia Obremskey has been investing in women for her entire career, believing that the two most impactful things you can do for the world are to educate women and give them tools to manage their fertility. She is currently a Co-founder and Managing Partner at Foreground Capital, a venture capital firm investing in early-stage women’s health start-ups. Stasia co-founded and led Foreground’s precursor funds at RH Capital, where she and her team built one of the largest dedicated portfolios of venture-backed women’s health companies. At Foreground Capital, she continues to manage RH Capital funds and serves as a board director for Cadence OTC and as a board observer for Vitra Labs, Contraline, Gesynta, and YourChoice Therapeutics. She holds an MBA from Harvard Business School and a bachelor’s degree in Business Administration with a concentration in finance from the University of Notre Dame.